Letter to Registered Shareholder - New Arrangements on Dissemination of Corporate Communications and Reply Form
Filed with HKEX · Stock code 8158 · · 3 pages · English
Pursuant to Rule 16.04A of the Rules Governing the Listing of Securities on GEM of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) effective from 31 December 2023 and the articles of association (the “Articles” ) of China Regenerative Medicine International Limited (the “Company”), the Company is writing to inform you that the Company has adopted electronic dissemination of corporat
China Regenerative Medicine International Limited on 6ix
Earlier from China Regenerative Medicine International
- Interim Report 2026
- CEO Mr. Chen Chunguo Holds a Meeting with Government Official of Shaanxi Xixian New Area - Discuss the Strategic Deployment of Regenerative Medicine Industry Develop Hi-tech Cosmeceuticals Industrial Park
- R&D Team of “Acornea” Invited to Share the R&D and Application Experience of the First Chinese Bio- engineered Cornea at Oxford
- China Regenerative Medicine International: “Acornea” expands clinical applications Completed FDA registration
- Financial Secretary of HK SAR Paul Chan Mo-po Leads Delegation on Visit to the Group Encourages to Promote the Innovative Technology Development of Regenerative Medicine
Later from China Regenerative Medicine International
- Letter to Non-registered Shareholder - New Arrangements on Dissemination of Corporate Communications
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
Follow China Regenerative Medicine International into a list and get an email when it puts out news.
Follow China Regenerative Medicine International